BioSpace News Archive

Deals

Bausch Health Companies Inc. Begins Trading Today As “BHC” On NYSE And TSX

Bausch Health Launches New Corporate Web Site

July 16, 2018
·
3 min read
FDA

Stryker receives US FDA Pre-market approval for the Surpass Streamline™ Flow Diverter to treat large and giant unruptured aneurysms

Stryker Corporation announced that the U.S. Food and Drug Administration has granted pre-market approval (PMA) for the Surpass Streamline Flow Diverter to treat unruptured large and giant wide neck intracranial aneurysms.

July 16, 2018
·
2 min read
FDA

Braeburn Announces PDUFA Date for CAM2038 for the Treatment of Opioid Use Disorder

If approved, CAM2038 will provide patients and HCPs with flexible-dose weekly and monthly options for the treatment of opioid use disorder, with the goal of improving treatment adherence and reducing the burdens associated with daily medication.

July 16, 2018
·
3 min read
Biotech Beach

Pliant Therapeutics Raises $62 Million in Series B Financing to Advance Therapies for Fibrotic Diseases

Pliant Therapeutics, Inc. announced that it has raised $62 million in a Series B financing.

July 16, 2018
·
3 min read
Business

Cricket Health Appoints Dr. Carmen A. Peralta as Chief Medical Officer

Commitment to Patients at Heart of Multidisciplinary Care Program for Those with Kidney Disease

July 16, 2018
·
3 min read
Biotech Bay

Mizuho OSI® to Showcase Specialty Surgical and Operating Room Technology at FIME 2018

Solutions Available for Demonstration in Hall B, Booth E10

July 16, 2018
·
3 min read
Business

Nevro Announces Preliminary Unaudited Second Quarter 2018 Revenue and Updates Full Year 2018 Revenue Guidance

Company to Host Conference Call Today, Monday, July 16, 2018 at 5:30 a.m. PT / 8:30 a.m. ET

July 16, 2018
·
3 min read
Biotech Beach

Couple Overcomes Fertility Challenges and Setbacks with Aid from Kolb Fertility to Welcome Baby via IVF and Surrogacy

With help from Bradford Kolb, MD, FACOG, and his team at Kolb Fertility, Jana and Cory have fulfilled their dreams of having a child.

July 16, 2018
·
2 min read
Drug Development

Ironwood Pharmaceuticals Initiates Phase IIIb Study of Linaclotide in Adult Patients with Irritable Bowel Syndrome with Constipation (IBS-C)

Trial designed to more comprehensively evaluate the effect of linaclotide 290 mcg on bothersome abdominal symptoms, including bloating, discomfort and pain, associated with IBS-C.

July 16, 2018
·
8 min read
Drug Development

Fusion Pharma Announces Formation of Advisory Board

Inaugural Advisory Board Includes Internationally Renowned Experts In Oncology and Radiation Therapy.

July 16, 2018
·
7 min read